Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Brazil benefits from Merck's antiretroviral price cuts

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Brazil benefits from Merck's antiretroviral price cuts. Pharmacoecon. Outcomes News 311, 12 (2001). https://doi.org/10.1007/BF03280335

    Download citation

    Keywords

    • Public Health
    • Health Outcome
    • Health Economic
    • Outcome News
    • Generic Version